Latanoprost Versus Fotil

Phase 4

Completed

• Conditions: Ocular Hypertension; Open-Angle Glaucoma

• Registration Number: NCT00304785
• Lead Sponsor: Pharmaceutical Research Network

Brief Summary

To compare the intraocular pressure effect and safety of latanoprost 0.005% given every evening versus PTFC given twice daily.

Detailed Description

Not available

Study Timeline

• Study Start: 2005-05
• Study First Submitted: 2006-03-17
• Study First Submitted QC: 2006-03-17
• Study First Posted: 2006-03-20
• Status Verified: 2007-10
• Study Completion: 2007-10
• Last Update Submitted: 2007-10-23
• Last Update Posted: 2007-10-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 36

Inclusion Criteria

• adults with primary open-angle or pigment dispersion glaucoma, or ocular hypertension
• untreated intraocular pressure should be between 24-36 mm Hg inclusive
• visual acuity should be 5/50 or better in both eyes

Exclusion Criteria

• presence of exfoliation syndrome or exfoliation glaucoma
• contraindications to study medications
• any anticipated change in systemic hypotensive therapy

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Trial Locations

Locations (5)

Gabinety Okulistyczne; 🇵🇱 Bydgoszcz, Poland

Kierownik Kliniki Okulistycznej Akademii Medycznej; 🇵🇱 Poznan', Poland

Instytut Jaskry; 🇵🇱 Warsaw, Poland

Katdra Klinika Okulityki Akademii Medycznej w Warszawie; 🇵🇱 Warsaw, Poland

Ordynator Oddziału Okulistycznego Międzyleski Szpital Specjalistyczny; 🇵🇱 Warszawa, Poland